Follow Us:
Linkedin-in
Home
\
Upcoming MAP Programs

Upcoming MAP Programs

[tribe_events view="month"]

There are no upcoming events at this time

Stay Updated on New MAP Programs and Dates

As the market access environment changes, relevant topics will be covered through new programs. Subscribe below to be the first to know about new MAP Program topics and added dates for existing Programs.

*required





    Privacy Guaranteed — We will never share your info!

    Manufacturers Restricting 340B Sales to Contract Pharmacies

    • Abbvie
    • Amgen
    • AstraZeneca
    • Boehringer Ingelheim
    • Eli Lilly
    • Merck
    • Novartis
    • Novo Nordisk
    • Sanofi
    • UCB
    • United Therapeutics
    • and more…